Another glutamine transporter, SLC38A3, has been reported to promote tumor growth and metastasis in breast cancer and colorectal cancer, implying that SLC38A3 could be a potential therapeutic target in these cancers [73, 74]. This evidence concerns the gene SLC38A3 and breast carcinoma.